From In the Pipeline regarding AstraZeneca, but applicable to any large R&D centric company.
This entry was posted on Wednesday, February 8th, 2012 at 10:07 AM and is filed under Link.
You can follow any comments to this entry through the RSS 2.0 feed.
You can leave a comment, or trackback from your own site.
